Quote:

---

Then, explain who is going to report the news?

---

The media of course. A medical conference where we have only a poster on combined results from a study and two small trials isn't enough to gain traction. An approval with great results that beat everyone hands down will trickle up from pharma publications to the mainstream. Then the FOMO begins. That some brokerages won't trade it is meaningless because investors will use brokerages that do. With approval then we have a plan for sustainable income that we can submit to the NYSE or NASDAQ and we move to the big boards. Not to forget if our results in mssCRC mirror those in mTNBC there is possible accelerated approval.